Tevogen Bio Holdings Inc.

TVGN ·

Tevogen Bio Holdings Inc. (TVGN) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Tevogen Bio Holdings Inc. in 2026. The next earnings report is expected on November 24, 2026.

Earnings calendar

Next earnings date

24 Nov 2026

In 94 days

EPS estimate

-2.56

Revenue estimate

Past earnings

Date	EPS actual	Revenue actual	1d	5d	30d
14 Aug 2026	— estimate -2.54	— estimate 0	+2.37%	-2.41%	+4.37%
15 May 2026	— estimate -2.64	— estimate 0	+2.37%	-2.41%	+4.37%

14 Aug 2026

EPS actual

—

estimate -2.54

Revenue actual

—

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

15 May 2026

EPS actual

—

estimate -2.64

Revenue actual

—

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Sector: Healthcare
Industry: Biotechnology
Country: United States
Exchange: Nasdaq
CEO: Ryan H. Saadi
Employees: 18
ISIN: US88165K1016
Website: tevogen.com

Frequently asked questions

When does Tevogen Bio Holdings Inc. (TVGN) next report earnings?

Tevogen Bio Holdings Inc. (TVGN) is scheduled to report earnings on November 24, 2026.

What was Tevogen Bio Holdings Inc.'s most recent earnings date?

Tevogen Bio Holdings Inc. (TVGN) last reported earnings on August 14, 2026.

Where is Tevogen Bio Holdings Inc. stock listed?

Tevogen Bio Holdings Inc. (TVGN) is listed on Nasdaq.